pembrolizumab
merck
['kn826', 'pembro']
happy to see kn826 updated results: unprecedented median os in cervical cancer with the addition of pembrolizumab to 1st line ct. most of these patients are in lmic. access remains the biggest challenge! #asco23 
Medical Oncologist - Instituto do Câncer do Estado de São Paulo @ICESP_ - Oncologia D’Or #BreastCancer #GynecologicCancer